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Background: Bacterial resistance to commonly used antimicrobials is an increasing problem in Asia but
information concerning the antimicrobial susceptibility of bacteria causing urinary tract infections (UTIs)
in children is limited.
Methods: This was a 5-year retrospective study of children with suspected UTI attending a paediatric
hospital in north-west Cambodia. Urines with a positive culture containing a single organism with a
count of w105 colony-forming units (CFU)/ml were considered diagnostic of infection. The organism
was identified and the resistance pattern (using CLSI guidelines) and presence of an extended-spectrum
b-lactamase (ESBL) phenotype was determined.
Results: In total, there were 217 episodes of infection, 210 (97%) with Gram-negative bacteria.
Escherichia coli was the most common infecting isolate with high levels of resistance to most oral
antibiotics, except nitrofurantoin. Nearly half of the E. coli (44%) were extended-spectrum cephalosporin
(ESC)-resistant with the proportion increasing significantly over the 5-year period. ESC-resistant E. coli
were more likely to be multi-drug-resistant and 91% demonstrated an ESBL phenotype.
Conclusion: The data highlight the importance of microbiological surveillance of UTIs in children,
particularly in areas where there are known to be multiply resistant organisms.
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Introduction
Urinary tract infections (UTI) are common in children,
and as many as 2% of children have been diagnosed
with at least one UTI by the age of 10 years.1 Prompt
and appropriate antimicrobial therapy should lead to
rapid recovery and the avoidance of complications.
Delayed or incorrect antibiotic treatment may result
in recurrence, particularly in children with renal
abnormalities who risk developing progressive renal
damage with hypertension and chronic renal failure.2,3
Vesico-ureteric reflux VUR) is the most common
underlying urinary tract disorder associated with
UTI in children.4
Antibiotic choice should be based on local circulating
bacterial strains and resistance profiles, which vary
between countries. In a number of epidemiological sur-
veys, the commonest aetiological cause of UTI in chil-
dren has been Escherichia coli.5,6 Increasing levels of
infection with extended-spectrum b-lactamase (ESBL)-
producing E. coli strains have been described in
Phnom Penh, the capital of Cambodia, and neighbour-
ing countries.7–9We report the species and antimicrobial
susceptibility of bacteria causing UTIs in children
attending a paediatric hospital in north-westCambodia.
Methods
Patients
This was a retrospective analysis of laboratory data
routinely collected by the Microbiology Department
in Angkor Hospital for Children (AHC), Siem Reap
town, north-west Cambodia. This charitable hospital
provides medical care to Cambodian children (v16
years) free of charge and has 70 beds with approxi-
mately 125,000 attendances and 4000 admissions
per year. Urine samples submitted to the laboratory
between 1 January 2007 and 31 December 2011 were
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studied. Because of the association between UTI
and bacteraemia,10 the hospital database was exam-
ined to discover whether any patients with UTI infec-
tions had concomitant bacteraemia.
Laboratory methods
Urine samples (mid-stream clean-catch samples for
older children and a urine bag for younger children
and infants) were examined by microscopy. Samples
containing w10 white blood cells/ml were cultured
semi-quantitatively on Oxoid Brilliance UTI clarity
agar (Oxoid, Basingstoke, UK) and incubated aerobi-
cally at 37uC for 18–24 hours. Cultures of a single
organism with a count ofw105 colony-forming units
(CFU)/ml were considered to represent infection and
were identified using appropriate routine identification
methods includingGram-stain, an in-house short set of
biochemical tests and a commercial biochemical ana-
lytical profile index kit (API, BioMe´rieux, France).
Routine diagnostic antimicrobial susceptibility results
were determined using the disk diffusion method for
ampicillin, co-amoxiclav, co-trimoxazole, ciprofloxa-
cin and gentamicin in accordance with the Clinical
and Laboratory Standards Institute guidelines
(CLSI),11 anddata for these routine testswere retrieved
from laboratory records. Repeat, confirmatory, sus-
ceptibility testing for these antimicrobials and for
species identification and additional susceptibility test-
ing were performed on fresh sub-cultures of frozen,
clinical isolates which had been stored at {80uC for
quality assurance and to minimise differences caused
by changes in interpretive guidelines over the 5-year
period. Additional susceptibility tests were undertaken
for nitrofurantoin, mecillinam, fosfomycin, chloram-
phenicol, imipenem and amikacin (the latter for
gentamicin-resistant isolates only). E. coli and Kleb-
siella species resistant to extended-spectrum cephalos-
porins (ESC, ceftriaxone, cefpodoxime or ceftazidime)
were examined for ESBL/AmpC beta-lactamase
(AmpC) activity in accordance with CLSI guidelines.
Repeat isolates cultured from the same patient
were considered to be duplicate isolates representing
a single infection if isolated within a 3-month period.
The age and gender of the child and year of isolation
was also recorded.
Data analysis
Data were analysed using Stata 13?1 (StataCorp, TX,
USA). Fishers Exact and x2 tests were performed to
examine the difference in antimicrobial susceptibilities
over time, and Pv0?05 was taken as significance.
Ethics approval
Ethics approval of the study was granted by the AHC
Institutional Review Board, Siem Reap, Cambodia
and the Oxford Tropical Research Ethics Committee,
UK.
Results
During the study period, 28,732 samples were pro-
cessed by the laboratory (w5000/year) and approxi-
mately 800 samples were cultured each year. In 2011,
for example, 725 urines were cultured: there was no
growth in 39?7% (288), growth of v104 CFU/ml in
35?9% (260), mixed growth of more than two organ-
isms in 10?6% (77), pure growth of 104–105 CFU/ml
in 1?9% (13), and pure growth of a single isolate at
w105 CFU/ml in 11?6% (84). Over the study period,
226 single isolates were retrieved. Nine strains were
considered to be duplicates, leaving 217 episodes of
infection for analysis during the 5-year period. Age
and gender were known for 213 patients: 66?2% (141)
were female and the median age (inter-quartile range,
range) was 1?73 years (10 mths to 6?2 yrs, 13 days to
16 yrs). There were 161 (74%) samples submitted
from children in the outpatient department and
56 (26%) from in-patients. A blood culture was taken
at the same time in 76 (35%) children with a UTI:
three blood samples were positive for the same organ-
ism (Klebsiella pneumoniae in two and E. coli in one).
Organisms
There were Gram-negative bacteria in 97% (210/217)
of isolates with E. coli being the most common organ-
ism (170/217 isolates, 78%). Other identifiable Gram-
negative isolates were K. pneumoniae (8?8%), Proteus
mirabilis (2%), Pseudomonas (2%), Acinetobacter
species (2%), and Burkholderia cepacia, Citrobacter
freundii and Serratia species (one isolate each). All
isolated Gram-positive organisms were Enterococcus
species (3%); no staphylococci were isolated.
Antimicrobial susceptibility patterns
The antimicrobial susceptibilities of the most common
organisms, E. coli and K. pneumoniae, are shown in
Table 1. Resistance to most antibiotics tested was
common in both organisms. E. coli resistance to
ampicillin was present in 96% (164/170) whereas
K. pneumoniae are intrinsically resistant to ampicillin.
For E. coli andK. pneumoniae combined, co-amoxiclav
resistance was present in 81% (153/189), co-trimoxazole
in 87% (165/189), ciprofloxacin in 47% (89/189), genta-
micin in 49% (92/189) and ESC in 44% (84/189). Only
7% (12/188) of strains were resistant to nitrofurantoin.
Statistically significant differences in resistance preva-
lence between E. coli and K. pneumoniae were observed
for gentamicin (45% E. coli-resistant vs 79%
K. pneumoniae, P50?005), ESC (40% vs 84%,
P50?005) and nitrofurantoin (4% vs 26%, Pv0?001).
The proportion of E. coli strains resistant to ESC
increased significantly over the 5-year period (overall
P50?01), but this was not the case for K. pneumoniae
(P50?34). Of the 68 E. coli strains resistant to
ESC tested, 62 (91%) had an ESBL phenotype
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and 19 (28%) were resistant to cefoxitin, suggesting the
presence of an AmpC enzyme; 13 (19%) strains were
both ESBL positive and resistant to cefoxitin. E. coli
strains with ESC resistance were significantly more
likely to be also resistant to ampicillin (P50?04), co-
amoxiclav (Pv0?001), ciprofloxacin (Pv0?001) and
gentamicin (Pv0?001) than those which were ESC-
susceptible (Table 2). The majority of E. coli strains
were susceptible to mecillinam (135/169, 80%), fosfo-
mycin (168/169, 99%), amikacin (76/76, 100% of
those resistant to gentamicin), nitrofurantoin (163/
169, 96%), chloramphenicol (90/169, 53%) and imipe-
nem (169/169, 100%).
Discussion
This study has demonstrated very high levels of
resistance to antibiotics in E. coli isolates causing
UTIs in Cambodian children. Less than one quarter
of isolates were susceptible to oral antibiotics such as
amoxicilin, co-amoxiclav and co-trimoxazole which
are commonly used to treat UTIs in local children.
The high levels of resistance to ESC means that
oral cephalosporins would also be unsuitable, and
the high levels of ciprofloxacin resistance rule it out
as a reliably effective second-line choice. Suscepti-
bility to nitrofurantoin, fosfomycin and mecillinam
was examined, although they are not commonly
used locally. Although nitrofurantoin is affordable
($8 for 100 tablets) and available in Cambodia, it is
not routinely used, but fosfomycin and mecillinam
are not currently available to purchase in Cambodia.
Resistance was v1% for fosfomycin and 18–22% for
mecillinam, suggesting that fosfomycin may be effec-
tive in the current setting. In a study conducted in the
capital, Phnom Penh, resistance to fosfomycin was
observed in adults.13 The resistance to mecillinam,
not seen in other studies, suggests that this antibiotic
should be used with caution in our setting.14–16 For
children with urosepsis, gentamicin, ESC and cipro-
floxacin would not be reliable empirical choices.
The carbapenems and amikacin would be more pre-
dictably active, but these are not widely available in
most local health-care settings. The data from this
study has been disseminated to physicians working
at AHC and has contributed to the development of
the hospital’s antimicrobial guidelines.
Table 1 Antimicrobial susceptibilities for urinary Escherichia coli and Klebsiella pneumoniae by year of isolation
E. coli, n (%) susceptible by year K. pneumoniae, n (%) susceptible by year*
2007 2008 2009 2010 2011 Total 2007 2008 2009 2010 Total
n537 n542 n540 n528 n523 n5170 P-value n56 n56 n54 n53 n519 P-value
Ampicillin 2 (5) 1 (2) 2 (5) 1 (4) 0 6 (4) 0?80 - - - - - -
Co-amoxiclav 14 (38) 6 (14) 10 (25) 2 (7) 2 (9) 34 (20) 0?02 1 (17) 0 0 1 (33) 2 (11) 0?51
Co-trimoxazole 5 (14) 5 (12) 6 (15) 5 (19) 2 (9) 23 (14) 0?90 0 1 (17) 0 0 1 (5) 1?00
Nitrofurantoin 37 (100) 39 (93) 38 (97) 28 (100) 21 (91) 163{ (96) 0?21 4 (67) 4 (67) 4 (100) 2 (67) 14 (74) 0?74
Ciprofloxacin 26 (70) 22 (52) 19 (48) 17 (61) 9 (39) 93 (55) 0?13 3 (50) 2 (33) 0 2 (67) 7 (37) 0?30
Gentamicin 20 (54) 23 (55) 22 (45) 16 (57) 13 (57) 94 (55) 1?00 2 (33) 1 (17) 0 1 (33) 4 (21) 0?70
ESCz 31 (84) 22 (52) 23 (58) 16 (57) 10 (43) 102 (60) 0?01 2 (33) 0 0 1 (33) 3 (16) 0?28
P-value derived from the logistic regression assessing the significance of changes in susceptibility over time; * No K. pneumoniae
isolated in 2011; { only 169 isolates tested; z extended-spectrum cephalosporin
Table 2 Comparison of the antimicrobial susceptibilities of Escherichia coli isolates according to their susceptibility to
extended-spectrum cephalosporins
Extended-spectrum cephalosporin (ESC) result
Antibiotic susceptibility
Total no. susceptible
n5170 (% of tested) Susceptible n5102 (60%) Resistant n568 (40%) P-value
Ampicillin 6 (4) 6 (5?9) 0 0?04
Co-amoxiclav 102 (60) 34 (33) 0 v0?001
Co-trimoxazole 23 (14) 18 (18) 5 (7) 0?06
Nitrofurantoin 163 (96) 99* (98) 64 (94) 0?18
Ciprofloxacin 93 (55) 77 (75) 16 (24) v0?001
Gentamicin 94 (55) 73 (72) 21 (31) v0?001
Mecillinam 135 (81) 79* (78) 56 (82) 0?51
Imipenem 169{ (100) 101* (100) 68 (100) NT
(all susceptible)
Fosfomycin 168{ (99) 100* (99) 68 (100) 0?41
Amikacinz 76{ (100) 29* (100) 47 (100) NT
(all susceptible)
Chloramphenicol 90{ (53) 57* (56) 33 (49) 0?31
*The one strain unable to be resuscitated was ESC-susceptible and therefore only 101 ESC-susceptible strains could be analysed
for these antibiotics; { 169 samples tested, one strain could not be resuscitated for further testing; z amikacin was tested only on
strains resistant to gentamicin (n576); NT, not tested
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The rates of resistance were consistent with data
from an earlier study in the Cambodian capital
(2004–2005) performed mainly in adults.12 Suscepti-
bility to the ESC and co-amoxiclav decreased signifi-
cantly over the 5-year study period. Many of the
resistant strains demonstrated an ESBL phenotype
although the exact enzymes involved have not been
determined; in earlier published data these were
shown to mostly contain CTX-M-14 or CTX-M-27
variants.12 Isolates with ESC were also commonly
resistant to gentamicin and ciprofloxacin.
The study has a number of limitations. It is likely
that many of these children had already been pre-trea-
ted with antibiotics in the community but had not
responded, given that in Cambodia antibiotics are
available over the counter and without prescription.12
Information about prior treatment was not routinely
documented and might be unreliable. In a recent
study, antibiotic activity could be detected in the
urine of one third of children attending the AHC out-
patient department.17 Prior treatment is also likely
among children admitted to hospital. This might
have resulted in overestimating the real prevalence of
resistance in community-associated UTIs. The data
were collected retrospectively and it is possible that
some patients presenting with UTI symptoms might
not have been registered on the electronic database
and were missed. Furthermore, in the absence of
relevant clinical data it is not certain that all episodes
represented true infections. Additional data such as
malnutrition, known to be prevalent in Cambodian
children,18 were not available for the current study.
Prospective studies of urinary tract disorders in chil-
dren would allow collection of more comprehensive
clinical and demographic information.
It is difficult to obtain a clean-catch urine sample
from young children, and a number of children with
genuine infections, but with a mixed growth cultured
from urine, may have been misclassified. The presence
of white cells in the urine and significant growth
(w105 CFU/mL) of a single organism is widely used
as a diagnostic measure by which to identify the
majority of significant infections. There was only a
handful ofK. pneumoniae isolates, and therefore limited
power to detect any significant trends in resistance.
Three children had a bacteraemia diagnosed at the
same time as the UTI but these data may be limited if
urine samples were not sent from all septic patients on
admission to the hospital.
The data emphasise the value of microbiological
examination of urine in children who have not
responded to an initial course of antibiotics, and suggest
the circulationofmultiply resistantE. coli isolates in this
setting. The high levels of resistance are consistent with
the worldwide increase in the incidence of disease
caused by resistant organisms, most notably ESBL-
producing organisms.19 It is likely that multiple factors
are contributing to this increase, including the easy
availability of over-the-counter antimicrobials in
countries in south-east Asia such as Cambodia, the
inadequate quality of prescriptions dispensed and the
variable quality of the drugs.20 The lack of new antimi-
crobials means that therapeutic options for many
common infections such as UTI are narrowing. The
work highlights the critical importance of pathogen
and resistance surveillance over time.
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